Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Lenalidomide Is Safe and Active in Waldenstrom Macroglobulinemia (WM)

Xavier Leleu, MD, Steven Legouill, MDPhD, Chanaz Louni, Karlin Lionel, MD, Anne Banos, MD, Bertrand Arnulf, Marie Odile Petillon, MD, Olivier Tournilhac, MD, Pierre Morel, MD, Veronique Leblond, MD PhD

Blood (2014) 124 (21): 4478.

https://doi.org/10.1182/blood.V124.21.4478.4478

Published: 2014

Journal Articles

Upfront Allogeneic-Stem Cell Transplantation for Patients with Non-Localized Untreated Peripheral T-Cell Lymphoma: An Intention-to-Treat Analysis from a Single Center

Blood (2014) 124 (21): 1217.

https://doi.org/10.1182/blood.V124.21.1217.1217

Published: 2014

Journal Articles

Relative Stability Of Plasma Cells Immunophenotype In Multiple Myeloma Over Time

Benoit Tessoulin, Steven Legouill, MD PhD, Marion Eveillard, Nelly Robillard, Soraya Wuilleme, Thomas Gastinne, MD, Cyrille Touzeau, MD, Catherine Pellat-Deceunynck, PhD, Marie C Bene, PharmSciD, PhD, Philippe Moreau, MD

Blood (2013) 122 (21): 1885.

https://doi.org/10.1182/blood.V122.21.1885.1885

Published: 2013

Journal Articles

Fludarabine, IV Busulfan and Antithymocyte Globulins-Based Reduced-Toxicity Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation (allo-SCT): Results of a Multicenter Prospective Trial

Mohamad Mohty, Didier Blaise, MD, Myriam Labopin, Noel Milpied, MD, Sabine Furst, MD, Reza Tabrizi, MD, Thierry Guillaume, Stephane Vigouroux, MD, Jean El-Cheikh, MD PhD, Jacques Delaunay, MD, Steven Legouill, MD PhD, Philippe Moreau, MD, Patrice Chevallier, MD

Blood (2012) 120 (21): 1926.

https://doi.org/10.1182/blood.V120.21.1926.1926

Published: 2012

Journal Articles

Outcome After 9/10 Mismatched Unrelated Donor or Cord Blood Cells Allogeneic Stem Cell Transplantation (allo-SCT) in the Setting of Reduced-Intensity Conditioning (RIC)

Florent Malard, Sabine Furst, MD, Marion Loirat, Patrice Chevallier, MD, Jean El-Cheikh, MD PhD, Thierry Guillaume, MD, Jacques Delaunay, MD, Steven Legouill, MD PhD, Philippe Moreau, MD, Didier Blaise, MD, Mohamad Mohty, MD PhD

Blood (2012) 120 (21): 956.

https://doi.org/10.1182/blood.V120.21.956.956

Published: 2012

Journal Articles

No Benefit of First-Line Rituximab (R) - High-Dose Therapy (R-HDT) Over R-CHOP14 for Young Adults with Diffuse Large B-Cell Lymphoma. Preliminary Results of the GOELAMS 075 Prospective Multicentre Randomized Trial

Noel-Jean Milpied, MD, Steven Legouill, Thierry Lamy, Vincent Delwail, Remy Gressin, MD, Denis Guyotat, Gandhi Damaj, MD, Charles Foussard, MD, Philippe Quittet, MD, Herve Maisonneuve, MD, Eric Deconinck, Francois Dreyfus, MD, Emmanuel Gyan, MD, PhD, Laurent Sutton, Nadine Morineau, MD, Magda Alexis, MD, Frederic Perry, Mathieu Sauvezie

Blood (2010) 116 (21): 685.

https://doi.org/10.1182/blood.V116.21.685.685

Published: 2010

Journal Articles

Impact of Cyclosporine a (CsA) Concentration on the Incidence of Severe Acute Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (allo-SCT).

Florent Mallard, Eolia Brissot, Patrice Chevallier, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Viviane Dubruille, Steven Legouill, Beatrice Mahe, Thomas Gastinne, Nicolas Blin, Beatrice Saulquin, Philippe Moreau, Jean-Luc Harousseau, Mohamad Mohty

Blood (2008) 112 (11): 1150.

https://doi.org/10.1182/blood.V112.11.1150.1150

Published: 2008

Journal Articles

Late Relapse of Localized High-Grade Non-Hodgkin’s Lymphoma: Clinical and Biological Features

Gandhi Damaj, MD, Marc Bernard, MD, Steven Legouill, MD, Guillaume Cartron, MD, PhD, Annie Le Mevel, MD, Céline Dubus, Christian Berthou, MD, PhD, Philippe Colombat, MD, PhD, Noel Milpied, MD, PhD, Jean Pierre Marolleau, MD, PhD, Thierry Lamy, MD, PhD

Blood (2008) 112 (11): 2603.

https://doi.org/10.1182/blood.V112.11.2603.2603

Published: 2008

Journal Articles

The Small-Molecule VEGF-Receptor Inhibitor Pazopanib (GW786034B) Targets Both Tumor and Endothelial Cells in Multiple Myeloma.

Klaus Podar, MD, MSc, PhD, Giovanni Tonon, MD, PhD, Martin Sattler, PhD, Yu-Tzu Tai, PhD, Steven LeGouill, MD, Hiroshi Yasui, MD, PhD, Kenji Ishitsuka, MD, PhD, Rakesh Kumar, PhD, Lini N. Pandite, MD, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2006) 108 (11): 5003.

https://doi.org/10.1182/blood.V108.11.5003.5003

Published: 2006

Journal Articles

The JAK Inhibitor INCB20 Induces Antiproliferative and Apoptotic Effects in Human Myeloma Cells In Vitro and In Vivo .

Renate Burger, PhD, Steven Legouill, MD, Yu-Tzu Tai, PhD, Reshma Shringarpure, PhD, Klaus Podar, MD, PhD, Laurence Catley, MD, Pierfrancesco Tassone, MD, Paola Neri, MD, Teru Hideshima, MD, Dharminder Chauhan, PhD, Eian Caulder, BS, Kris Vaddi, PhD, Claire L. Neilan, PhD, Martin Gramatzki, MD, Jordan S. Fridman, PhD, Kenneth C. Anderson, MD

Blood (2005) 106 (11): 3357.

https://doi.org/10.1182/blood.V106.11.3357.3357

Published: 2005

Journal Articles

Up-Regulation of c-Jun contributes to the Induction of Apoptosis by Adaphostin in Human Multiple Myeloma Cells.

Klaus Podar, MD, PhD, Giovanni Tonon, MD, PhD, Marc S. Raab, MD, Martin Sattler, PhD, Dean Abtahi, BS, Yu-Tzu Tai, PhD, Steven LeGouill, MD, PhD, Kenji Ishitsuka, MD, PhD, Hiroshi Yasui, MD, PhD, Ron A. Depinho, MD, Teru Hideshima, MD, PhD, Dharminder Chauhan, JD, PhD, Kenneth C. Anderson, MD

Blood (2005) 106 (11): 1585.

https://doi.org/10.1182/blood.V106.11.1585.1585

Published: 2005

Journal Articles

Inhibition of Human Plasmacytoma Cell Growth by a Novel JAK Kinase Inhibitor.

Blood (2004) 104 (11): 644.

https://doi.org/10.1182/blood.V104.11.644.644

Published: 2004

NARROW

Lenalidomide Is Safe and Active in Waldenstrom Macroglobulinemia (WM)

Upfront Allogeneic-Stem Cell Transplantation for Patients with Non-Localized Untreated Peripheral T-Cell Lymphoma: An Intention-to-Treat Analysis from a Single Center

Relative Stability Of Plasma Cells Immunophenotype In Multiple Myeloma Over Time

Fludarabine, IV Busulfan and Antithymocyte Globulins-Based Reduced-Toxicity Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation (allo-SCT): Results of a Multicenter Prospective Trial

Outcome After 9/10 Mismatched Unrelated Donor or Cord Blood Cells Allogeneic Stem Cell Transplantation (allo-SCT) in the Setting of Reduced-Intensity Conditioning (RIC)

No Benefit of First-Line Rituximab (R) - High-Dose Therapy (R-HDT) Over R-CHOP14 for Young Adults with Diffuse Large B-Cell Lymphoma. Preliminary Results of the GOELAMS 075 Prospective Multicentre Randomized Trial

Impact of Cyclosporine a (CsA) Concentration on the Incidence of Severe Acute Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (allo-SCT).

Late Relapse of Localized High-Grade Non-Hodgkin’s Lymphoma: Clinical and Biological Features

The Small-Molecule VEGF-Receptor Inhibitor Pazopanib (GW786034B) Targets Both Tumor and Endothelial Cells in Multiple Myeloma.

The JAK Inhibitor INCB20 Induces Antiproliferative and Apoptotic Effects in Human Myeloma Cells In Vitro and In Vivo .

Up-Regulation of c-Jun contributes to the Induction of Apoptosis by Adaphostin in Human Multiple Myeloma Cells.

Inhibition of Human Plasmacytoma Cell Growth by a Novel JAK Kinase Inhibitor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only